Items where Author is "Tolaymat, Ibrahim"
![]() | Up a level |
Journal Article
Pereira, Ana Maria ORCID: https://orcid.org/0000-0002-3829-242X, Kaya, Ayse, Alves, Dan, Ansari-Fard, Niusha
ORCID: https://orcid.org/0000-0002-1931-534X, Tolaymat, Ibrahim
ORCID: https://orcid.org/0000-0001-8903-8299, Arafat, Basel and Najlah, Mohammad
ORCID: https://orcid.org/0000-0001-7670-2859
(2022)
Preparation and Characterization of Disulfiram and Beta Cyclodextrin Inclusion Complexes for Potential Application in the Treatment of SARS-CoV-2 via Nebulization.
Molecules, 27 (17).
ISSN 1420-3049
Said Suliman, Ammar, Khoder, Mouhamad, Tolaymat, Ibrahim, Webster, Matt, Alany, Raid G., Wang, Weiguang, Elhissi, Abdelbary M. A. and Najlah, Mohammad (2021) Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines. Pharmaceutics, 13 (1). p. 84. ISSN 1999-4923
Said Suliman, Ammar, Tom, Rose, Palmer, Kirsty, Tolaymat, Ibrahim, Younes, Husam M., Arafat, Basel, Elhissi, Abdelbary M. A. and Najlah, Mohammad (2020) Development, characterization and stability evaluation of ciprofloxacin-loaded parenteral nutrition nanoemulsions. Pharmaceutical Development and Technology, 25 (5). pp. 579-587. ISSN 1083-7450
Najlah, Mohammad, Said Suliman, Ammar, Tolaymat, Ibrahim, Kurusamy, Sathishkumar, Kannappan, Vinodh, Elhissi, Abdelbary M. A. and Wang, Weiguang (2019) Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment. Pharmaceutics, 11 (11). p. 610. ISSN 1999-4923
Sherer, Christopher, Prabhu, Saurabh, Adams, David, Hayes, Joseph, Rowther, Farzana, Tolaymat, Ibrahim, Warr, Tracy and Snape, Timothy J. (2018) Towards Identifying Potent New Hits for Glioblastoma. MedChemComm, 11 (9). pp. 1850-1861. ISSN 2040-2511
Sherer, Christopher, Tolaymat, Ibrahim, Rowther, Farzana, Warr, Tracy and Snape, Timothy J. (2017) Preliminary SAR on indole-3-carbinol and related fragments reveals a novel anticancer lead compound against resistant glioblastoma cells. Bioorganic and Medicinal Chemistry Letters, 27 (7). pp. 1561-1565. ISSN 1464-3405